JERRI BINGHAM: Open Payments
NPI 1063834224 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 8 payments from 7 companies in 2025. Trend: 2023 $59 · 2024 $286 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Telix Pharmaceuticals | 1 | $100 |
| Astellas Pharma US Inc | 1 | $98 |
| Grifols USA, LLC | 1 | $80 |
| Janssen Biotech, Inc. | 1 | $69 |
| Sumitomo Pharma America, Inc. | 1 | $62 |
| TOLMAR, INC. | 1 | $52 |
| ABBVIE INC. | 2 | $42 |
Products named: GOZELLIX, Xtandi, Prolastin-C Liquid, RYBREVANT, GEMTESA, JATENZO, BOTOX.
Industry payments across ID — which companies pay providers there.
